We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AT&T
T
$164B
| $374M | 0.49% |
17,196,301
-745,198
| -4% | -$17M |
|
27
Abbott
ABT
$187B
| $360M | 0.47% |
3,109,205
-101,351
| -3% | -$11.8M |
|
28
Salesforce
CRM
$154B
| $360M | 0.47% |
1,473,481
-58,797
| -4% | -$13.6M |
|
29
Coca-Cola
KO
$383B
| $356M | 0.47% |
6,572,201
-392,538
| -6% | -$21.4M |
|
30
PepsiCo
PEP
$196B
| $346M | 0.45% |
2,334,589
-154,415
| -6% | -$22.5M |
|
31
Netflix
NFLX
$307B
| $343M | 0.45% |
6,492,970
-219,550
| -3% | -$11.2M |
|
32
Walmart Inc
WMT
$909B
| $341M | 0.45% |
7,248,297
-30,144
| -0.4% | -$1.4M |
|
33
Chevron
CVX
$382B
| $335M | 0.44% |
3,197,326
-161,851
| -5% | -$17.1M |
|
34
Pfizer
PFE
$143B
| $328M | 0.43% |
8,383,861
-608,030
| -7% | -$23.6M |
|
35
Nike
NKE
$64.1B
| $325M | 0.43% |
2,105,128
-100,496
| -5% | -$13.5M |
|
36
Texas Instruments
TXN
$248B
| $319M | 0.42% |
1,658,979
-67,568
| -4% | -$12.7M |
|
37
Costco
COST
$432B
| $315M | 0.41% |
795,904
-34,054
| -4% | -$12.9M |
|
38
Broadcom
AVGO
$1.76T
| $312M | 0.41% |
6,550,600
-302,890
| -4% | -$14M |
|
39
Accenture
ACN
$106B
| $311M | 0.41% |
1,055,251
-55,083
| -5% | -$15.8M |
|
40
Wells Fargo
WFC
$254B
| $310M | 0.41% |
6,843,805
-54,011
| -0.8% | -$2.41M |
|
41
Eli Lilly
LLY
$1.08T
| $309M | 0.41% |
1,346,582
-68,918
| -5% | -$13.8M |
|
42
Thermo Fisher Scientific
TMO
$214B
| $307M | 0.4% |
608,891
-31,721
| -5% | -$15M |
|
43
McDonald's
MCD
$193B
| $303M | 0.4% |
1,309,954
-72,360
| -5% | -$16.8M |
|
44
Merck
MRK
$322B
| $302M | 0.4% |
3,885,418
-382,611
| -9% | -$28.5M |
|
45
AbbVie
ABBV
$465B
| $302M | 0.4% |
2,681,494
-151,918
| -5% | -$17.1M |
|
46
Danaher
DHR
$138B
| $272M | 0.36% |
1,144,982
-50,388
| -4% | -$11.2M |
|
47
Medtronic
MDT
$112B
| $269M | 0.35% |
2,166,915
-102,718
| -5% | -$12.9M |
|
48
Qualcomm
QCOM
$164B
| $269M | 0.35% |
1,880,526
-102,734
| -5% | -$13.9M |
|
49
Oracle
ORCL
$339B
| $264M | 0.35% |
3,389,939
-296,304
| -8% | -$23.2M |
|
50
Union Pacific
UNP
$174B
| $257M | 0.34% |
1,168,847
-53,733
| -4% | -$12M |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.